Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 21 Nov 2022

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

in Hematologic Malignancies

Xin-Yu Zhuang
Zheng-Tai Sun
Yue Xu
Ya-Ru Ren
Ying-Jie Chen
Feng Chen
Xiao Ma
Xiao-Wen Tang
Xiao-Feng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1040679

2,060 views
1 citation

Review

Published on 18 Nov 2022

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

in Hematologic Malignancies

Cyrus R. Kumana
Yok-Lam Kwong
Harinder Gill

Frontiers in Oncology

doi 10.3389/fonc.2022.1026478

5,597 views
4 citations

Original Research

Published on 17 Nov 2022

Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma

in Hematologic Malignancies

Tao Guan
Min Zhang
Xiaolan Liu
Jing Li
Beibei Xin
Yanxin Ren
Yuchao Yang
Hui Wang
Mengjing Zhao
Yunpeng Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1003957

5,417 views
9 citations

Original Research

Published on 17 Nov 2022

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis

in Hematologic Malignancies

Hongye Gao
Meng Wu
Shaoxuan Hu
Ning Ding
Xinqiang Ji
Lan Mi
Xiaopei Wang
Yuqin Song
Jun Zhu
Weiping Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1039888

3,164 views
3 citations

Methods

Published on 15 Nov 2022

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach

in Hematologic Malignancies

Núria Rodríguez Ruiz
Sulaf Abd Own
Karin Ekström Smedby
Sandra Eloranta
Sabine Koch
Tove Wästerlid
Aleksandra Krstic
Magnus Boman

Frontiers in Oncology

doi 10.3389/fonc.2022.984021

7,340 views
10 citations

Mini Review

Published on 15 Nov 2022

Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder

in Hematologic Malignancies

José C. Martínez
Eben I. Lichtman

Frontiers in Oncology

doi 10.3389/fonc.2022.1002253

6,172 views
18 citations

Original Research

Published on 14 Nov 2022

Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD

in Hematologic Malignancies

Marie Schwarz
Sophie Rizzo
Walter Espinoza Paz
Anne Kresinsky
Damien Thévenin
Jörg P. Müller

Frontiers in Oncology

doi 10.3389/fonc.2022.1017947

3,639 views
9 citations

Review

Published on 14 Nov 2022

Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

in Hematologic Malignancies

Huijuan Zhao
Ziqing Wei
Guomin Shen
Yixiang Chen
Xueqin Hao
Sanqiang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1045797

6,007 views
12 citations

Brief Research Report

Published on 10 Nov 2022

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece

in Hematologic Malignancies

Eleni Gavriilaki
Athanasios Tragiannidis
Maria Papathanasiou
Sotiria Besikli
Paraskevi Karvouni
Vassiliki Douka
Eleni Paphianou
Emmanuel Hatzipantelis
Giorgos Papaioannou
Anastasia Athanasiadou

Frontiers in Oncology

doi 10.3389/fonc.2022.947410

7,400 views
4 citations

Original Research

Published on 10 Nov 2022

Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma

in Hematologic Malignancies

Shuxin Huang
Yujie Zhao
Pengjun Liao
Jinghua Wang
Zhiyan Li
Jiaxiong Tan
Xianfeng Zha
Shaohua Chen
Yangqiu Li
Liye Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.1014904

4,629 views
22 citations

Review

Published on 10 Nov 2022

Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance

in Hematologic Malignancies

Tadeusz Robak
Paweł Robak

Frontiers in Oncology

doi 10.3389/fonc.2022.976374

5,673 views
5 citations

Original Research

Published on 10 Nov 2022

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma

in Hematologic Malignancies

Yuan Chen
Hu Zhao
Jing Luo
Youping Liao
Xu Dan
Guoyu Hu
Weiyue Gu

Frontiers in Oncology

doi 10.3389/fonc.2022.944511

2,896 views
6 citations

Review

Published on 09 Nov 2022

Dysregulation of FBW7 in malignant lymphoproliferative disorders

in Hematologic Malignancies

Xin Wan
Wei Guo
Zhumei Zhan
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2022.988138

3,763 views
2 citations

Original Research

Published on 07 Nov 2022

NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia

in Hematologic Malignancies

Lucero Valenzuela-Vázquez
Juan Carlos Nuñez-Enriquez
Jacqueline Sánchez-Herrera
Aurora Medina-Sanson
María Luisa Pérez-Saldivar
Elva Jiménez-Hernández
Jorge Alfonso Martiín-Trejo
María de Los Ángeles Del Campo-Martínez
Janet Flores-Lujano
Raquel Amador-Sánchez

Frontiers in Oncology

doi 10.3389/fonc.2022.1023510

7,261 views
10 citations

Editorial

Published on 07 Nov 2022

Editorial: Real-World evidence in onco-hematological patients

in Hematologic Malignancies

Claudia Vener
Matteo Franchi
Annalisa Trama

Frontiers in Oncology

doi 10.3389/fonc.2022.1060802

1,826 views

Review

Published on 03 Nov 2022

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

in Hematologic Malignancies

Taotao Li
Gaoling Zhang
Xiaoling Zhang
Hai Lin
Qiuju Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1015792

7,859 views
13 citations

Review

Published on 02 Nov 2022

Acquired and hereditary bone marrow failure: A mitochondrial perspective

in Hematologic Malignancies

Waseem Nasr
Marie-Dominique Filippi

Frontiers in Oncology

doi 10.3389/fonc.2022.1048746

6,157 views
8 citations

Original Research

Published on 31 Oct 2022

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma

in Hematologic Malignancies

Karolina Piechna
Aleksandra Żołyniak
Ewa Jabłońska
Monika Noyszewska-Kania
Maciej Szydłowski
Bartłomiej Żerek
Maria Kulecka
Izabela Rumieńczyk
Michał Mikula
Przemysław Juszczyński

Frontiers in Oncology

doi 10.3389/fonc.2022.1048741

4,427 views
5 citations

Case Report

Published on 31 Oct 2022

Acute necrotizing encephalopathy associated with lymphoma-associated hemophagocytic lymphohistiocytosis: A case report and literature review

in Hematologic Malignancies

Wenqiang Sun
Changchang Fu
Xueping Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.986957

2,896 views
4 citations

Editorial

Published on 31 Oct 2022

Editorial: Novel mechanisms for the treatment of AML before and after transplant

in Hematologic Malignancies

Margaret T. Kasner

Frontiers in Oncology

doi 10.3389/fonc.2022.1063307

1,473 views

Original Research

Published on 31 Oct 2022

Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients

in Hematologic Malignancies

Thibault Andrieu
Paul Mondière
Pierre-Emmanuel Jouve
Sébastien Dussurgey
Victor Malassigné
Hugo Servanton
Lucille Baseggio
Frédéric Davi
Anne-Sophie Michallet
Thierry Defrance

Frontiers in Oncology

doi 10.3389/fonc.2022.1020740

3,392 views
4 citations

Review

Published on 28 Oct 2022

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia

in Hematologic Malignancies

Alexander J. Ambinder
Amy E. DeZern

Frontiers in Oncology

doi 10.3389/fonc.2022.1033534

9,520 views
12 citations

Systematic Review

Published on 27 Oct 2022

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis

in Hematologic Malignancies

Jianyu Hu
Xue Zhang
Huan Tao
Yongqian Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.1034398

5,419 views
13 citations

Editorial

Published on 27 Oct 2022

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies

in Hematologic Malignancies

Haojian Zhang
Pengxu Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.1037202

1,592 views

2,058 articles

articles

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach

Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder

Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD

Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece

Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma

Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma

Dysregulation of FBW7 in malignant lymphoproliferative disorders

NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia

Editorial: Real-World evidence in onco-hematological patients

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

Acquired and hereditary bone marrow failure: A mitochondrial perspective

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma

Acute necrotizing encephalopathy associated with lymphoma-associated hemophagocytic lymphohistiocytosis: A case report and literature review

Editorial: Novel mechanisms for the treatment of AML before and after transplant

Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies